Prostate cancer IV is stage 4.

Written by Cui Fang Bo
Oncology
Updated on November 09, 2024
00:00
00:00

Prostate cancer stage IV refers to stage four prostate cancer, which is a common type of male reproductive organ tumor, particularly prevalent among elderly men. Stage four prostate cancer means that the tumor is not confined to the prostate and has already shown corresponding distant metastasis. The most common sites of metastasis for prostate cancer are the bones, followed by the lungs, liver, and others. When metastasis of prostate cancer occurs, it is considered to be at a late stage, and the primary treatments include endocrine therapy, chemotherapy, etc., with a poor prognosis.

Other Voices

doctor image
home-news-image
Written by Yan Chun
Oncology
53sec home-news-image

Is prostate cancer stage T2 considered early or mid-stage?

Prostate cancer stage T2 is considered early or intermediate, but it is also necessary to understand the patient's N and M status. If the patient is at stage T2, and both N and M are at stage 0, then it is considered early-stage prostate cancer. If the primary lesion is at stage T2, but N1 is present and there is no metastasis (M), then the patient is considered to have intermediate-stage prostate cancer. If the primary lesion is at stage T2, but there is metastasis in N and M, then the patient's clinical stage is considered advanced. The clinical staging of prostate cancer not only requires understanding of the primary lesion T, but also involves the regional lymph nodes N and distant metastasis M.

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
40sec home-news-image

androgen deprivation therapy for prostate cancer

Androgen deprivation therapy for prostate cancer includes surgical castration, which can quickly and continuously reduce levels to very low levels. The second is medical castration, which involves the use of analogs of luteinizing hormone-releasing hormone. Currently available products include leuprolide, goserelin, and triptorelin. Third, estrogen therapy, with diethylstilbestrol being the most common estrogen treatment. Surgical castration, medical castration, or estrogen therapy offer similar progression-free survival rates in patients with tumor-related outcomes.

doctor image
home-news-image
Written by Liu Liang
Oncology
39sec home-news-image

Is there a treatment for prostate cancer?

The treatment methods for prostate cancer include surgery, radical surgery, radiotherapy, endocrine therapy, and chemotherapy. The choice of treatment is related to the stage of the cancer, as different stages require different treatment plans. Early-stage prostate cancer patients can choose radical surgery or radical radiotherapy. For patients with advanced prostate cancer, the first choice of treatment is endocrine therapy, and chemotherapy can be used after endocrine therapy fails, or some palliative radiotherapy, etc., depending on the specific situation.

doctor image
home-news-image
Written by Xiao Li
Oncology
59sec home-news-image

Can prostate cancer patients eat milk and eggs?

Prostate cancer is the most common malignant tumor in the male urinary reproductive system, with 80% of cases occurring in elderly individuals over the age of 65. From an etiological perspective, a high-fat diet may be a contributing factor to prostate cancer. However, we know that malignant tumors are consumptive diseases, and nutritional status is crucial during the treatment and recovery process, especially in elderly individuals with weaker constitutions. Therefore, patients with malignant tumors should ensure adequate nutrition intake, particularly protein intake. Milk and eggs are common foods for the general population and offer a cost-effective source of nutrition. They can be included in the diet of prostate cancer patients. Of course, dietary intake should focus on healthy proportions. It is not about consuming only milk and eggs at every meal but maintaining a normal and healthy dietary balance, which is better for the patient.

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
34sec home-news-image

How long can one live after prostate cancer has spread to the bones?

Bone metastasis is the most common site of metastasis for prostate cancer. If a patient with prostate cancer develops bone metastasis, it means that the cancer is no longer in its early stages and has progressed to a more advanced stage. However, unlike other cancers with a higher degree of malignancy, if the tumor is highly sensitive to hormone therapy, with standardized treatment, the patient's survival time can be significantly extended.